April 7, 2016
Synthace Ltd., a London, U.K.- based technology company developing Antha, a language and operating system for working with biology, has entered into a strategic partnership with Microsoft to use Azure cloud analytics, cognitive services, and machine learning.
“We are excited about Antha’s ability to transform the productivity of working with biology, from genomics, to drug discovery, to bio manufacturing,” said Geoff Hughes, Business Development at Microsoft.
According to Sean Ward, founder and chief technology officer of Synthace, “biological experimentation is in crisis. Understanding complex systems is impossible if the underlying working practices are as highly variable and failure prone as they are today.
“Powerful advances in AI and deep learning are of little use without sufficient and structured experimental data to train them on …”
Antha is an open-source language that provides a description of working practices, which can then be translated, using the AnthaOS operating system, into automated execution on hardware from different vendors.
It also ensures that structured data is produced from every experiment. The result for the user is enhanced traceability, reproducibility and simplicity.
Andrew Phillips, head of bio computation at Microsoft Research said that “as we develop the next generation of biodesign software technologies it is critical to be able to translate them into the real world. Antha solves the current disconnect and major bottleneck between this digital to physical transition enabling us to build and apply advanced tools to understand and engineer biology.”